Peter Vavrinec

Peter Vavrinec

Auto-generated profile, based on publicly available information

Peter Vavrinec

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2026 in Molecular Biology Reports
Verified
Journal Article
Open access
VVVeronika Vyletelová
Veronika Vyletelová
MBMarek Bohunčák
Marek Bohunčák
JHJana Hricovíniová
Jana Hricovíniová
GGGabriela Greifová
Gabriela Greifová
PVPeter Vavrinec
Peter Vavrinec
LPLudmila Paskova
Ludmila Paskova
Background: Chronic inflammatory diseases are associated with qualitative and quantitative changes in lipid and lipoprotein metabolism, including high density lipoproteins (HDLs), increasing patients´ susceptibility to atherosclerosis and cardiovascular mortality. Given the liver’s central role in lipoprotein metabolism and systemic inflammation, we aimed to develop and investigate an in vitro model of inflammation-induced hepatic metabolic changes. Methods and Results: To better approximate in vivo conditions, where systemic inflammation exposes the liver to a complex environment rich in cytokines and inflammatory mediators, we exposed human hepatocarcinoma HepG2 cells to conditioned media (CM) from THP-1-derived macrophages using phorbol-12-myristate-13-acetate (PMA) and lipopolysaccharide (LPS). The effect of CM on mRNA expression in HepG2 was tested by quantitative real-time PCR or protein expression by Western blot analysis. Even short-term exposure to CM (2–4 h) led to a significant change in the mRNA expression of inflammatory genes and several transcription factors (e.g., TNF-α, NF-κB, PPARα, and LRH-1). This change was accompanied by alternations in the expression of lipoprotein-associated genes at different time points (e.g. SAA, LDLr, ApoA1, ABCA1, PON1, and PCSK9). After 24 h of exposure, no effect on HepG2 viability was observed. Conclusion: In our model, we observed several significant inflammation-induced changes in hepatic lipoprotein metabolism, making it a valuable in vitro system for further mechanistic studies.